Participate in an Alzheimer’s Research Study
If you or someone you love is experiencing memory loss, or has been diagnosed with Alzheimer’s disease, perhaps you should consider participating in a clinical research study. Participants receive a high standard of care, and research shows that people involved in clinical trials tend to do somewhat better than people in a similar stage of their disease who are not enrolled in clinical trials.*
Health insurance is not necessary to participate. Patients who qualify for our clinical trials will receive all study related care and treatment at no cost. In some cases you may be compensated for your time and travel. You may even gain access to research treatments before they are widely available.
Interested in learning about our Alzheimer’s research studies? Contact the Premiere Research Institute of Palm Beach by calling (561) 296-3824 or fill out the form below.
Perhaps the best reason to participate in an Alzheimer’s clinical trial is so that you can take an active role in your health care, by educating yourself regarding your condition. You will obtain access to top quality medical care from our Board Certified physicians at a medical research healthcare facility specializing in Alzheimer’s care.
Without volunteers for clinical trials, improved treatments, including a cure for Alzheimer’s disease can never become a reality.
Premiere Research Institute is currently seeking volunteers for the LAURIET Study.
What is the LAURIET study?
The LAURIET Study from Genentech will test how safe the investigational medication is and whether it works in affecting Alzheimer’s Disease. The study will also use imaging (using a scanner to make a detailed picture) to look at how the investigational medication affects certain substances in the brain.
Some patients in the study will receive a placebo (which looks the same as the investigational medication but contains no actual medication). Other people will receive the investigational medication. This way the researchers can see if there is any difference in effect between people receiving the investigational medication and people receiving placebo. You will have a 50% chance (1 in 2) of receiving the investigational medication and a 50% chance of receiving placebo.
Who can take part?
You may be able to take part in the LAURIET Study if you are 50 to 85 years of age with moderate Alzheimer’s Disease (for example, confusion about dates and locations, difficulty recalling important events, and needing help with dressing). You need somebody who can be a reliable study partner or caregiver and who can come to some study visits with you and answer questions about your health.
Click here for more information
Articles about Alzheimer’s Disease
To read one of our most recent articles about Alzheimer’s Disease just click the title of the article.
Untreated Hearing Loss May Accelerate Cognitive Decline and Dementia Evidence suggests that age-related hearing loss, particularly in those over the age of 65, can lead to cognitive decline and dementia if left untreated. Impairments in communication and psychosocial...read more
What is The MIND Diet? The MIND diet is based on the Mediterranean and DASH (Dietary Approach to Systolic Hypertension) diets, with an emphasis on natural plant-based foods and limited consumption of saturated fats and animal-based foods. The MIND diet, which is...read more
In the search for lifestyle strategies that slow cognitive decline associated with aging, medical researchers have been investigating the protective effects that certain dietary regimens could have on the brain. A study published in the journal Alzheimer’s & Dementia...read more
A study published in the Journal of Alzheimer’s Disease found that elderly adults who burned off more calories each week through physical exercise saw an increase in brain volume and a subsequent lower risk for Alzheimer’s disease. Although many studies have shown...read more
A form of gene therapy has yielded positive findings in the search for a potential cure to Alzheimer’s disease, according to research published from the journal Proceedings of the National Academy of Sciences. Researchers in the United Kingdom from Imperial College...read more
The risk factors for Alzheimer's disease are non-modifiable, physiological, and behavioral. Non-modifiable risk factors include age, which is the most prominent risk factor for Alzheimer’s disease. At 65 years of age, our chances of getting Alzheimer’s disease is...read more
According to new research, inflammation brain changes related to Alzheimer’s disease may begin as early as 20 years before symptoms develop. This discovery has significant implications for prevention of the disease, since addressing the inflammation earlier in life...read more
Overview: Alzheimer’s disease is a chronic, degenerative and progressive disease of the brain characterized by a loss of neurons and synapses and is currently ranked as the 7th leading cause of death in the United States. According to the Alzheimer’s Association, an...read more
Over the years, there have been a growing number of studies that have revealed a link between hearing loss and dementia, which may in turn lead to Alzheimer’s if left untreated. In fact, research has shown that mild hearing loss may double the risk of dementia, while...read more
High blood pressure, or hypertension, is a growing health problem in many parts of the world that serves as a major risk factor for cardiovascular disease and stroke. In addition, new evidence is emerging on a significant association between high blood pressure and...read more